Fig. 3From: Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysisMeta-analysis compared cisplatin-based chemoradiotherapy versus cetuximab-based bioradiotherapy in estimating patients in HPV+ subgroup regarding to OS, PFS, and LRC. OS, overall survival; PFS, progression-free survival; LRC, locoregional controlBack to article page